NCT01936649View on ClinicalTrials.gov

Open-label, Test-retest Study Assessing Reproducibility of Quantitative Measurements of Myocardial Uptake of AdreView.

PHASE4CompletedINTERVENTIONAL
Enrollment

63

Participants

Timeline

Start Date

August 31, 2013

Primary Completion Date

February 28, 2014

Study Completion Date

February 28, 2014

Conditions
Heart Failure (HF)Ventricular Dysfunction, Left
Interventions
DRUG

AdreView (Iobenguane I 123 Injection)

AdreView 10 mCi as a single i.v administration

Trial Locations (1)

08540

GE Healthcare, Princeton

Sponsors

Lead Sponsor

GE Healthcare

Collaborators (1)

H2O Clinical LLC
All Listed Sponsors
collaborator

H2O Clinical LLC

INDUSTRY

collaborator

Quintiles, Inc.

INDUSTRY

lead

GE Healthcare

INDUSTRY